[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![MarketRebels Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::817007725666242561.png) Market Rebellion [@MarketRebels](/creator/twitter/MarketRebels) on x 347.2K followers
Created: 2025-07-17 18:24:00 UTC

Sarepta surges after strategic overhaul, cutting XX% of workforce & prioritizing siRNA assets. Aims for $400M annual savings, reaches FDA deal on ELEVIDYS labeling. $SRPT @jonnajarian  @petenajarian  #ITSNOTANOPTION

![](https://pbs.twimg.com/amplify_video_thumb/1945899580236726272/img/EFQnTS3Yor4zkogs.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945912384205513145/c:line.svg)

**Related Topics**
[$srpt](/topic/$srpt)
[$400m](/topic/$400m)
[sarepta therapeutics inc](/topic/sarepta-therapeutics-inc)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/MarketRebels/status/1945912384205513145)